|4Feb 23, 4:54 PM ET

Ellis Christopher 4

4 · Vaccitech plc · Filed Feb 23, 2023

Insider Transaction Report

Form 4
Period: 2023-01-03
Ellis Christopher
Chief Operating Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2023-01-03+105,000105,000 total
    Exercise: $2.40Exp: 2033-01-03Ordinary Shares (105,000 underlying)
Footnotes (2)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]This option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 3, 2024.

Documents

1 file
  • 4
    tm237643-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT